Literature DB >> 10205269

A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32.

M Varret1, J P Rabès, B Saint-Jore, A Cenarro, J C Marinoni, F Civeira, M Devillers, M Krempf, M Coulon, R Thiart, M J Kotze, H Schmidt, J C Buzzi, G M Kostner, S Bertolini, M Pocovi, A Rosa, M Farnier, M Martinez, C Junien, C Boileau.   

Abstract

Autosomal dominant hypercholesterolemia (ADH), one of the most frequent hereditary disorders, is characterized by an isolated elevation of LDL particles that leads to premature mortality from cardiovascular complications. It is generally assumed that mutations in the LDLR and APOB genes account for ADH. We identified one large French pedigree (HC2) and 12 additional white families with ADH in which we excluded linkage to the LDLR and APOB, implicating a new locus we named "FH3." A LOD score of 3.13 at a recombination fraction of 0 was obtained at markers D1S2892 and D1S2722. We localized the FH3 locus to a 9-cM interval at 1p34.1-p32. We tested four regional markers in another set of 12 ADH families. Positive LOD scores were obtained in three pedigrees, whereas linkage was excluded in the others. Heterogeneity tests indicated linkage to FH3 in approximately 27% of these non-LDLR/non-APOB ADH families and implied a fourth locus. Radiation hybrid mapping located four candidate genes at 1p34.1-p32, outside the critical region, showing no identity with FH3. Our results show that ADH is genetically more heterogeneous than conventionally accepted.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205269      PMCID: PMC1377874          DOI: 10.1086/302370

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23-q24.

Authors:  A P Wojciechowski; M Farrall; P Cullen; T M Wilson; J D Bayliss; B Farren; B A Griffin; M J Caslake; C J Packard; J Shepherd
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

2.  Low density lipoprotein metabolism and receptor studies in a patient with pseudohomozygous familial hypercholesterolaemia.

Authors:  L Masana; J Joven; J Rubiés-Prat; B Lewis
Journal:  Acta Paediatr Scand       Date:  1990-04

3.  Exclusion mapping.

Authors:  J H Edwards
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

4.  Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2.

Authors:  S W Law; K J Lackner; A V Hospattankar; J M Anchors; A Y Sakaguchi; S L Naylor; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

5.  cDNAs encoding members of a family of proteins related to human sterol carrier protein 2 and assignment of the gene to human chromosome 1 p21----pter.

Authors:  Z He; R Yamamoto; E E Furth; L J Schantz; S L Naylor; H George; J T Billheimer; J F Strauss
Journal:  DNA Cell Biol       Date:  1991-10       Impact factor: 3.311

6.  LDLR Database (second edition): new additions to the database and the software, and results of the first molecular analysis.

Authors:  M Varret; J P Rabés; R Thiart; M J Kotze; H Baron; A Cenarro; O Descamps; M Ebhardt; J C Hondelijn; G M Kostner; Y Miyake; M Pocovi; H Schmidt; H Schuster; M Stuhrmann; T Yamamura; C Junien; C Béroud; C Boileau
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

7.  Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.

Authors:  T L Innerarity; K H Weisgraber; K S Arnold; R W Mahley; R M Krauss; G L Vega; S M Grundy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

8.  Human genes involved in cholesterol metabolism: chromosomal mapping of the loci for the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase with cDNA probes.

Authors:  V Lindgren; K L Luskey; D W Russell; U Francke
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.

Authors:  T Yamamoto; C G Davis; M S Brown; W J Schneider; M L Casey; J L Goldstein; D W Russell
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

10.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

View more
  29 in total

1.  A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree.

Authors:  Kirsten M Timms; Susanne Wagner; Mark E Samuels; Kristian Forbey; Howard Goldfine; Srikanth Jammulapati; Mark H Skolnick; Paul N Hopkins; Steve C Hunt; Donna M Shattuck
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

Review 2.  Monogenic hypercholesterolemia: new insights in pathogenesis and treatment.

Authors:  Daniel J Rader; Jonathan Cohen; Helen H Hobbs
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

3.  Clinical significance of single nucleotide polymorphisms in PCSK9.

Authors:  Ali J Marian
Journal:  Curr Atheroscler Rep       Date:  2007-09       Impact factor: 5.113

Review 4.  LDL, HDL, VLDL, and CVD Prevention: Lessons from Genetics?

Authors:  Bernd Hewing; Ulf Landmesser
Journal:  Curr Cardiol Rep       Date:  2015-07       Impact factor: 2.931

Review 5.  The PCSK9 decade.

Authors:  Gilles Lambert; Barbara Sjouke; Benjamin Choque; John J P Kastelein; G Kees Hovingh
Journal:  J Lipid Res       Date:  2012-07-17       Impact factor: 5.922

6.  A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1.

Authors:  Alice Marques-Pinheiro; Marie Marduel; Jean-Pierre Rabès; Martine Devillers; Ludovic Villéger; Delphine Allard; Jean Weissenbach; Maryse Guerin; Yassine Zair; Danièle Erlich; Claudine Junien; Arnold Munnich; Michel Krempf; Marianne Abifadel; Jean-Philippe Jaïs; Catherine Boileau; Mathilde Varret
Journal:  Eur J Hum Genet       Date:  2010-06-23       Impact factor: 4.246

7.  Oestrogen-modulated gene expression in the human endometrium.

Authors:  C Punyadeera; H Dassen; J Klomp; G Dunselman; R Kamps; F Dijcks; A Ederveen; A de Goeij; P Groothuis
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

8.  Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene.

Authors:  Mariame El Messal; Karima Aït Chihab; Rachid Chater; Joan Carles Vallvé; Faïza Bennis; Aïcha Hafidi; Josep Ribalta; Mathilde Varret; Mohammed Loutfi; Jean Pierre Rabès; Anass Kettani; Catherine Boileau; Luis Masana; Ahmed Adlouni
Journal:  J Hum Genet       Date:  2003-03-18       Impact factor: 3.172

9.  Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype.

Authors:  Kara N Maxwell; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

10.  The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation.

Authors:  Nabil G Seidah; Suzanne Benjannet; Louise Wickham; Jadwiga Marcinkiewicz; Stephanie Belanger Jasmin; Stefano Stifani; Ajoy Basak; Annik Prat; Michel Chretien
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.